DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
18. 脊髄小脳変性症(多系統萎縮症を除く。)
Spinocerebellar degeneration
Clinical trials
/
Disease details
臨床試験数
:
76
/
薬物数
:
98
- (
DrugBank
:
31
) /
標的遺伝子数
:
44
-
標的パスウェイ数
:
65
Search
1 trial found
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT02424435
(
ClinicalTrials.gov
)
June 2015
16/4/2015
Methylprednisolone
Treatment of Friedreich Ataxia
Open-label Pilot Study of
Methylprednisolone
for the Treatment of Patients With Friedreich Ataxia (FRDA)
Open-label Pilot Study of
Methylprednisolone
for the Treatment of Patients With Friedreich Ataxia (FR ...
Friedreich Ataxia
Drug:
Methylprednisolone
Children's Hospital of Philadelphia
Friedreich's Ataxia Research Alliance
Completed
5 Years
N/A
All
11
Early Phase 1
United States